FDA Inspection
Sligh, Teresa S. MDSligh, Teresa S. MD – FDA Inspection, Mar 1, 2016
Record Details
This FDA Inspection record concerns Sligh, Teresa S. MD, with an inspection on March 1, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Sligh, Teresa S. MD
- Inspection Date
- March 1, 2016
- Product Type
- Drugs
View Company Profile
ID · 7b994709-d8ad-45a5-94e4-b2c5a681ee54
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 962369
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sligh, Teresa S. MD
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 28, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 4, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 1, 2010 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
Other documents for Sligh, Teresa S. MD
- FDA Inspection 1165847 - 2022-03-28
- FDA Inspection 928743 - 2015-06-04
- FDA Inspection 650262 - 2010-03-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.